IP Library Granted Patent US 7,462,837
Granted Patent B2
US 7,462,837 · App. 11/661,221 · Granted Dec 9, 2008

Nuclide identifier system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,462,837
App. No.
11/661,221
Granted
Dec 9, 2008
Kind
B2
Abstract

In a preferred embodiment, a method of identifying nuclides, including the steps of: determining spectral continuum via a peak erosion process to render a residual peak spectrum; filtering a standard nuclide library specified by a user to select candidate nuclides; simultaneously fitting calibrations and activities of selected candidate nuclides from the standard library to the peak spectrum using a standard least squares method; calculating statistical significances of optimized nuclide activities and determining shape correlations between optimized candidate nuclide peak spectra and measured peak spectrum with alternative candidates subtracted; and identifying and providing activities of nuclides determined to have sufficiently significant activities and sufficient shape correlations.

Claims (16)

1. A method of identifying nuclides, comprising the steps of:

(a) determining spectral continuum via a peak erosion process to render a residual peak spectrum;

(b) filtering a standard nuclide library specified by a user to select candidate nuclides;

(c) simultaneously fitting calibrations and activities of selected candidate nuclides from said standard library to said peak spectrum using a standard least squares method;

(d) calculating statistical significances of optimized nuclide activities and determining shape correlations between optimized candidate nuclide peak spectra and measured peak spectrum with alternative candidates subtracted; and

(e) identifying and providing activities of nuclides determined to have sufficiently significant activities and sufficient shape correlations.

2. A method of identifying nuclides, as defined in claim 1 , further comprising:

step (b) includes selecting a candidate nuclide if activity of said nuclide is statistically significant compared to a threshold specified by a user.

3. A method of identifying nuclides, as defined in claim 1 , further comprising:

step (c) includes fitting parameters of nuclide amplitude/activities and energy calibration slope term.

4. A method of identifying nuclides, as defined in claim 3 , further comprising:

providing said calibration slope term, corresponding to gain shift, limited to within a specified gain shift tolerance to allow for some energy calibration drift.

5. A method of identifying nuclides, as defined in claim 1 , further comprising:

step (b) includes determining a maximum possible activity/amplitude over range of gain shift allowed by a specified % Gain Shift Tolerance.

6. A method of identifying nuclides, as defined in claim 1 , further comprising:

step (b) includes a user specifying an amplitude threshold that is used to designate candidate nuclides.

Assignments (9)
SECURITY INTEREST Recorded Oct 22, 2021
From: MIRION TECHNOLOGIES (HOLDINGSUB2), LTD.; MIRION TECHNOLOGIES (USHOLDINGS), INC.; MIRION TECHNOLOGIES (US), INC.; MIRION TECHNOLOGIES (CANBERRA), INC.; MIRION TECHNOLOGIES (CONAX NUCLEAR), INC.; SUN NUCLEAR CORP.; GAMMEX, INC.; MIRION TECHNOLOGIES (IST) CORPORATION; BIODEX MEDICAL SYSTEMS, INC.; MIRION TECHNOLOGIES (CAPINTEC), INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 057890/0509 →
RELEASE OF SECURITY INTEREST Recorded Oct 22, 2021
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: MIRION TECHNOLOGIES (RADOS) GMBH; MIRION TECHNOLOGIES (CANBERRA UK) LTD.; MIRION TECHNOLOGIES (CANBERRA) SAS; MIRION TECHNOLOGIES (CANBERRA), INC.; MIRION TECHNOLOGIES (CANBERRA), INC. (F/K/A CANBERRA INDUSTRIES, INC.); MIRION TECHNOLOGIES (CANBERRA) INC. (F/K/A MIRION TECHNOLOGIES (IMAGING), LLC); MIRION TECHNOLOGIES (IST) CORPORATION; MIRION TECHNOLOGIES, INC.; BIODEX MEDICAL SYSTEMS, INC.; GAMMEX, INC.; SUN NUCLEAR CORP.
Reel/Frame 057890/0970 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS (SECOND LIEN) Recorded Mar 13, 2019
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: MIRION TECHNOLOGIES (CANBERRA), INC. (FORMERLY KNOWN AS CANBERRA INDUSTRIES, INC.)
Reel/Frame 049033/0741 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS (FIRST LIEN) Recorded Mar 13, 2019
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: MIRION TECHNOLOGIES (CANBERRA), INC. (FORMERLY KNOWN AS CANBERRA INDUSTRIES, INC.)
Reel/Frame 048580/0892 →
SECURITY AGREEMENT Recorded Mar 11, 2019
From: MIRION TECHNOLOGIES (CANBERRA), INC.; MIRION TECHNOLOGIES (IMAGING), LLC; MIRION TECHNOLOGIES (IST) CORPORATION; MIRION TECHNOLOGIES, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 048556/0421 →
CHANGE OF NAME Recorded Jan 30, 2017
From: CANBERRA INDUSTRIES INC
To: MIRION TECHNOLOGIES (CANBERRA), INC
Reel/Frame 041550/0236 →
FIRST LIEN GRANT OF SECURITY INTEREST IN PATENT RIGHTS Recorded Aug 9, 2016
From: CANBERRA INDUSTRIES, INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
Reel/Frame 039633/0075 →
SECOND LIEN GRANT OF SECURITY INTEREST IN PATENT RIGHTS Recorded Aug 9, 2016
From: CANBERRA INDUSTRIES, INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
Reel/Frame 039633/0092 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2008
From: RUSS, WILLIAM R.
To: CANBERRA INDUSTRIES, INC.
Reel/Frame 021434/0738 →